Are high-cost prescription drugs the price of innovation? Disclose the costs of clinical trials
With 40 percent of Americans struggling to afford prescription medicines and many rationing or delaying initiation of lifesaving drugs, it’s clear something has gone terribly wrong. The goal of medical research and development (R&D) is to discover, develop, and deliver tools that meet pressing public health needs, but high prices prevent U.S. patients from accessing medicines critical for their care. In...